ArticleThe oncologist2025

Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer.

Wen-Kuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.